Gerber et al. demonstrated that protein 4.1B in meningioma could activate the Jun N-terminal kinase (JNK) by activating mixed-lineage kinase 3 (MLK3), which sequentially activates Src, rac1, and JNK. Here, MAP3K11 is linked to meningioma.